Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Ovarian Cancer
Antibody-Drug Conjugates
Clinical Trials
Biliary Tract Cancers
PARP Inhibitors
Chronic Lymphocytic Leukemia
Myelofibrosis
Gastroesophageal Cancers
Immunotherapy
Bevacizumab
Ruxolitinib
Lung Cancer
Acute Myeloid Leukemia
Myelodysplastic Syndromes
CA125
Palabresib
Pd-L1 Inhibitors
Gynecologic Oncology
Hepatobiliary Cancers
BTK Inhibitors

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes373Founded6 years ago
Number of ListenersCategories
MedicineScienceHealth & Fitness

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia... more

Prof Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year.

CME information and select publications here.... more

YouTube

Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.

NCPD information and sele... more

YouTube

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Hanny Al-Samkari
Medical oncologist discussing ASH 2025 key papers on ITP
Massachusetts General Hospital
Episode: Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
Hope Rugo
Dr Hope Rugo, City of Hope Comprehensive Cancer Center
City of Hope Comprehensive Cancer Center
Episode: Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Sara Tolaney
Dr Sara Tolaney, Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Hossein Borghaei
Dr. Hossein Borghaei, Fox Chase Cancer Center, Philadelphia
Fox Chase Cancer Center
Episode: Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
Anne Chiang
Dr. Anne Chiang, Yale Cancer Center, New Haven
Yale Cancer Center
Episode: Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
Stacey Cohn
University of Washington physician-scientist
University of Washington
Episode: Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis
Arvind Dasari
MD Anderson Cancer Center investigator
MD Anderson Cancer Center
Episode: Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis
Christopher Lieu
University of Colorado Cancer Center investigator
University of Colorado Cancer Center
Episode: Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis
Terence Friedlander
Medical oncologist at Zuckerberg San Francisco General Hospital
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Episode: Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review

Host

Dr Neil Love
Medical oncologist specializing in oncology practice and research.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#117
Hong Kong/Science
Apple Podcasts
#148
Israel/Science
Apple Podcasts
#150
South Korea/Science
Apple Podcasts
#214
India/Science

Talking Points

Recent interactions between the hosts and their guests.

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
Q: How did the Luna 3 results position Rilsabrutinib for ITP treatment compared with Yanolamab in YeHIT3?
Luna 3 showed a durable platelet response and meaningful fatigue improvements with Rilsabrutinib in a heavily pretreated population, with a higher threshold for response than YeHIT3's Yanolamab results; cross-study comparisons are imperfect, but both suggest activity in relapsed/refractory ITP and potential sequencing considerations.
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
Q: What do we know about adverse events and administration of enolamab in ITP?
Enolamab is given as a monthly IV infusion in ITP, with most infusion reactions being mild to moderate and around 10% experiencing an infusion reaction; premedication with corticosteroids helps mitigate reactions, and neutropenia can occur transiently in some patients but did not correlate with higher infection rates in trials.
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Q: What are the major data gaps and what future research is needed?
While ctDNA is the most prognostic tool observed in this setting, there is a need for more prospective randomized trials to determine the predictive value of ctDNA for chemotherapy benefit and to clarify how best to integrate serial ctDNA testing into standard care decisions beyond exploratory studies.
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Q: How does ctDNA testing influence adjuvant therapy decisions in stage II/III colon cancer?
ctDNA testing helps distinguish which patients are most likely to benefit from adjuvant chemotherapy. A positive ctDNA result after surgery suggests higher recurrence risk and supports proceeding with chemotherapy, while a consistently negative ctDNA result supports avoiding additional therapy. In low-risk stage II, a positive ctDNA can push clinicians toward treatment, whereas a negative ctDNA may reinforce the decision to withhold chemotherapy, with serial testing providing ongoing guidance.
Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Q: What is cell-free DNA and how is ctDNA detected in practice?
Cell-free DNA refers to DNA fragments shed into the bloodstream from normal and tumor cells. In ctDNA testing, blood is drawn and either a tumor-informed approach—where the patient's tumor alterations are known and specifically searched for—or a tumor-naïve approach—where broad mutations are scanned—are used. Tumor-informed tests like Signatera are highly sensitive because they target known cancer alterations from the individual's tumor, though they can take longer to return results.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Content focuses primarily on the latest advancements in oncology, featuring in-depth discussions between a medical oncologist and clinical investigators. Key topics include treatment protocols for various cancers, insights from recent clinical trials, and expert commentary on emerging therapies and practices. Noteworthy is the emphasis on personalized treatment strategies and the evolving landscape of therapies across multiple oncology domains, including bladder, prostate, and gynecologic cancers. Episodes highlight significant findings from major conferences that guide current clinical practices, making it a valuable resource for healthcare professionals seeking to stay updated on oncology innovations.

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Research To Practice | Oncology Videos
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Breast Cancer Update
4. Two Onc Docs
5. Hematologic Oncology Update

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 373 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Hanny Al-Samkari
2. Hope Rugo
3. Sara Tolaney
4. Hossein Borghaei
5. Anne Chiang
6. Stacey Cohn
7. Arvind Dasari
8. Christopher Lieu

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days